https://scholars.lib.ntu.edu.tw/handle/123456789/517920
標題: | Pharmacotherapy for primary delusional jealousy, a retrospective observational study of 32 cases with Othello syndrome | 作者: | CHEN-CHUNG LIU Wang Y.-C. TZUNG-JENG HWANG |
公開日期: | 2018 | 卷: | 33 | 期: | 2 | 起(迄)頁: | 92-97 | 來源出版物: | International Clinical Psychopharmacology | 摘要: | To determine whether primary delusional jealousy can be treated effectively with antipsychotics or antidepressants, and whether any clinical variables are associated with response to pharmacotherapy, we carried out a retrospective case series observational study by reviewing clinical records of patients with an International Classification of Disease, 9th ed., diagnostic code of 297 (delusional disorders) who were treated at the Department of Psychiatry of a university affiliated hospital from January 2010 to December 2015. Only those records showing obvious delusional jealousy not secondary to other medical conditions, dementia, or schizophrenia were scrutinized thoroughly with respect to types of pharmacotherapy, treatment response, and other demographic and clinical variables likely to be associated with clinical outcomes. All except one of 32 patients, 16 men and 16 women, between 37 and 79 (60.9±10.6) years of age, were treated with low-dose antipsychotics. The general response was favorable as 19 (59.4%) were rated as good and 13 as inadequate responders (seven partial and six limited). Compared with antipsychotic monotherapy, concomitant therapy with antidepressants had a higher rate of good response, although statistically insignificant (75 vs. 53%, P=0.21). Younger age (P=0.01) and presentation at the index visit with their suspected unfaithful spouse were associated with a good response (P=0.036); comorbidity with delusions other than the jealous type was associated with a poor response (P=0.006). The overall outcome for delusional jealousy looks promising if the patients can accept pharmacotherapy in an outpatient setting. Copyright ? 2018 The Author(s). Published by Wolters Kluwer Health, Inc. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045068779&doi=10.1097%2fYIC.0000000000000207&partnerID=40&md5=0225e7c7fcba7172858084be6cd90832 https://scholars.lib.ntu.edu.tw/handle/123456789/517920 |
ISSN: | 0268-1315 | DOI: | 10.1097/YIC.0000000000000207 | SDG/關鍵字: | amfebutamone; antidepressant agent; benzodiazepine derivative; escitalopram; hypnotic agent; neuroleptic agent; quetiapine; sertraline; sulpiride; venlafaxine; antidepressant agent; neuroleptic agent; quetiapine; sulpiride; adult; age; aged; Article; case study; clinical article; clinical outcome; female; human; jealous delusion; low drug dose; male; medical record review; middle aged; monotherapy; observational study; outcome assessment; priority journal; psychopharmacotherapy; retrospective study; treatment response; unspecified side effect; classification; combination drug therapy; delusion; dose response; drug monitoring; International Classification of Diseases; jealousy; paranoid schizophrenia; procedures; psychological rating scale; psychology; Taiwan; treatment outcome; Aged; Antidepressive Agents; Antipsychotic Agents; Delusions; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Female; Humans; International Classification of Diseases; Jealousy; Male; Middle Aged; Psychiatric Status Rating Scales; Quetiapine Fumarate; Schizophrenia, Paranoid; Sulpiride; Taiwan; Treatment Outcome |
顯示於: | 醫療器材與醫學影像研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。